HSDT
Income statement / Annual
Last year (2023), Helius Medical Technologies, Inc.'s total revenue was $644,000.00,
a decrease of 18.17% from the previous year.
In 2023, Helius Medical Technologies, Inc.'s net income was -$8.85 M.
See Helius Medical Technologies, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
03/31/2015 |
03/31/2014 |
| Operating Revenue |
$644,000.00
|
$787,000.00
|
$522,000.00
|
$661,000.00
|
$1.50 M
|
$478,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$745,000.00 |
$463,000.00 |
$298,000.00 |
$388,000.00 |
$846,000.00 |
$0.00 |
$0.00 |
$0.00 |
$171,781.00 |
$0.00 |
| Gross Profit |
-$101,000.00 |
$324,000.00 |
$224,000.00 |
$273,000.00 |
$650,000.00 |
$478,000.00 |
$0.00 |
$0.00 |
-$171,781.00 |
$0.00 |
| Gross Profit Ratio |
-0.16 |
0.41 |
0.43 |
0.41 |
0.43 |
1 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$2.94 M
|
$4.26 M
|
$5.99 M
|
$4.58 M
|
$8.06 M
|
$9.94 M
|
$14.39 M
|
$4.72 M
|
$3.83 M
|
$171,781.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$17.21 M
|
$8.47 M
|
$5.65 M
|
$4.26 M
|
$895,503.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$774,400.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$9.23 M
|
$10.64 M
|
$12.18 M
|
$9.71 M
|
$16.52 M
|
$17.21 M
|
$8.47 M
|
$5.65 M
|
$5.04 M
|
$895,503.00
|
| Other Expenses |
$80,000.00 |
$181,000.00 |
$200,000.00 |
$363,000.00 |
$64,000.00 |
$63,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$12.17 M |
$15.08 M |
$18.37 M |
$14.66 M |
$24.65 M |
$27.15 M |
$22.85 M |
$10.37 M |
$8.86 M |
$1.07 M |
| Cost And Expenses |
$12.91 M |
$15.55 M |
$18.66 M |
$15.05 M |
$25.49 M |
$27.15 M |
$22.85 M |
$10.37 M |
$8.86 M |
$1.07 M |
| Interest Income |
$0.00 |
$834,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$111,000.00 |
$20,074.00 |
$0.00 |
| Interest Expense |
$257,000.00 |
$834,000.00 |
$0.00 |
$0.00 |
$0.00 |
$1.95 M |
$5.17 M |
$1.67 M |
$176,488.00 |
$0.00 |
| Depreciation &
Amortization |
$162,000.00
|
$306,000.00
|
$374,000.00
|
$482,000.00
|
$191,000.00
|
$59,000.00
|
$17,000.00
|
$1.78 M
|
$20,074.00
|
$0.00
|
| EBITDA |
-$12.11 M
|
-$16.09 M
|
-$17.95 M
|
-$14.10 M
|
-$37.93 M
|
-$24.61 M
|
-$17.67 M
|
-$8.60 M
|
-$8.84 M
|
-$1.07 M
|
| EBITDA Ratio |
-18.8 |
-20.45 |
-34.39 |
-21.33 |
-25.35 |
-51.47 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-19.05
|
-18.75
|
-34.75
|
-21.76
|
-16.04
|
-55.81
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$3.42 M
|
$687,000.00
|
$10,000.00
|
$256,000.00
|
$14.22 M
|
-$1.95 M
|
-$5.17 M
|
-$1.78 M
|
$126,541.00
|
$0.00
|
| Income Before Tax |
-$8.85 M |
-$14.07 M |
-$18.13 M |
-$14.13 M |
-$9.78 M |
-$28.62 M |
-$28.02 M |
-$12.04 M |
-$8.89 M |
-$1.07 M |
| Income Before Tax Ratio
|
-13.74
|
-17.88
|
-34.74
|
-21.38
|
-6.54
|
-59.88
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$5,895.00 |
-$1.51 M |
-$10,000.00 |
-$193,000.00 |
-$14.12 M |
$3.96 M |
$10.34 M |
$1.67 M |
-$146,615.00 |
$0.00 |
| Net Income |
-$8.85 M |
-$12.56 M |
-$18.12 M |
-$13.94 M |
$4.34 M |
-$28.62 M |
-$28.02 M |
-$12.04 M |
-$8.89 M |
-$1.07 M |
| Net Income Ratio |
-13.74 |
-15.96 |
-34.72 |
-21.08 |
2.9 |
-59.88 |
0 |
0 |
0 |
0 |
| EPS |
-14.56 |
-46.52 |
-368.82 |
-581.8 |
288.15 |
-2198.39 |
-2632.1 |
0 |
-27.29 |
0 |
| EPS Diluted |
-14.56 |
-46.52 |
-368.82 |
-581.8 |
288.15 |
-2198.22 |
-2632.1 |
0 |
-27.29 |
0 |
| Weighted Average Shares
Out |
$607,890.00
|
$269,943.00
|
$49,135.00
|
$23,955.00
|
$15,058.00
|
$13,020.00
|
$10,647.00
|
$0.00
|
$325,986.00
|
$0.00
|
| Weighted Average Shares
Out Diluted |
$607,890.00
|
$269,943.00
|
$49,135.00
|
$23,955.00
|
$15,058.00
|
$13,021.00
|
$10,647.00
|
$0.00
|
$325,986.00
|
$0.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
